• Profile
Close

A randomized, 13-week study assessing the efficacy and metabolic effects of paliperidone palmitate injection and olanzapine in first-episode schizophrenia patients

Progress in Neuro-Psychopharmacology and Biological Psychiatry Jan 22, 2018

Huang M, et al. - The efficacy and metabolic effects of paliperidone palmitate (PP) injections against oral olanzapine were assessed in first-episode schizophrenia (FES) patients. In the treatment of FES patients, PP and olanzapine showed similar improvement. Furthermore, findings strengthened the necessity for regular monitoring of metabolic parameters in schizophrenia patients prescribed atypical antipsychotics.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay